Real Estate

Marcus & Millichap : Arranges Sale of a CVS Pharmacy in Miami for $6.05 Million

Press Releases

Marcus & Millichap Arranges Sale of a CVS Pharmacy in Miami for $6.05 Million

February 01, 2023

MIAMI, Feb. 01, 2023 – Marcus & Millichap (NYSE: MMI), a leading commercial real estate brokerage firm specializing in investment sales, financing, research and advisory services, announced today the sale of a 10,666-square-foot CVS Pharmacy in Miami, Florida. The property at 15700 S.W. 88th St. sold for $6.05 million.

“The ideal location and fantastic sales figures made this an extremely desirable property,” said Joseph Prio, retail division associate in the Marcus & Millichap Fort Lauderdale office. “Even with the rising interest rate market there is still high demand for South Florida net-lease properties.”

Prio, Barry M. Wolfe, and Alan Lipsky in Marcus & Millichap’s Fort Lauderdale office had the exclusive listing to market the property on behalf of the seller, FFT V Limited Partnership. Prio, Wolfe, and Lipsky also procured the buyer, a sister company of Gator Investments.

The 1.02-acre CVS Pharmacy has been a double-net leased, long-term tenant since 1997. The CVS Pharmacy is located at the signalized intersection of S.W. 88th St. and 157th Avenue, directly adjacent to Home Depot.

The CVS Pharmacy is within 11 miles of Miami Dade College Kendall Campus, Florida International University, Zoo Miami, and the University of Miami. The property is centrally located in the Hammocks Community, a suburb of Miami.

# # #

About Marcus & Millichap (NYSE: MMI)

Marcus & Millichap, Inc. is a leading brokerage firm specializing in commercial real estate investment sales, financing, research and advisory services with offices throughout the United States and Canada. As of December 31, 2021, the company had 1,994 investment sales and financing professionals in 82 offices who provide investment brokerage and financing services to sellers and buyers of commercial real estate. The company also offers market research, consulting and advisory services to clients. Marcus & Millichap closed 13,255 transactions in 2021, with a sales volume of approximately $84.4 billion. For additional information, please visit


Marcus & Millichap Inc. published this content on 01 February 2023 and is solely responsible for the information contained therein. Distributed by Public, unedited and unaltered, on 02 February 2023 19:00:08 UTC.

Publicnow 2023

All news about MARCUS & MILLICHAP, INC.

Analyst Recommendations on MARCUS & MILLICHAP, INC.

Sales 2022 1 300 M

Net income 2022 104 M

Net Debt 2022

P/E ratio 2022 14,1x
Yield 2022 4,13%
Capitalization 1 429 M
1 429 M
Capi. / Sales 2022 1,10x
Capi. / Sales 2023 1,22x
Nbr of Employees 801
Free-Float 96,6%


Duration :

Period :

Marcus & Millichap, Inc. Technical Analysis Chart | MarketScreener

Technical analysis trends MARCUS & MILLICHAP, INC.

Short Term Mid-Term Long Term
Trends Neutral Neutral Bearish

Income Statement Evolution



Mean consensus SELL
Number of Analysts 1
Last Close Price 36,32 $
Average target price 24,00 $
Spread / Average Target -33,9%

Source link